FDA Adverse Event Injury Summary report: N

FINELINE II

MDR report key: 1946245 · Received January 4, 2011

Report

Report Number
2124215-2010-21709
Event Type
Injury
Date Received
January 4, 2011
Date of Event
October 14, 2010
Report Date
November 4, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
P960004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Additional Manufacturer Narrative · 1

THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

WE RECEIVED ADDITIONAL INFORMATION INDICATING THIS SYSTEM HAS BEEN EXPLANTED DUE TO THE PATIENT INFECTION. NO ADVERSE PATIENT EFFECTS WERE EXPERIENCED DURING THE EXPLANT PROCEDURE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PRODUCT IS SCHEDULED TO BE EXPLANTED DUE TO A PATIENT INFECTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4469

Patients

Seq Age Sex Outcome Treatment
1 88 YR Required Intervention 4538| 4457| 1270| 4591| 4469| 4193| H120